Real-world use of systemic therapy in elderly patients with malignant pleural mesothelioma (MPM)

被引：0
|
作者：
Cedres, S. [1 ,2 ]
Assaf, J. D. [3 ]
Iranzo, P. [1 ,2 ]
Callejo, A. [1 ,2 ]
Pardo, N. [1 ,2 ]
Navarro, A. [1 ,2 ]
Martinez-Marti, A. [1 ,2 ]
Rodriguez, G. [1 ,2 ]
Monton, V. [1 ,2 ]
Gonzalo, J. [1 ]
Miquel, J. M. [1 ]
Pedrola, A. [1 ]
Dienstmann, R. [4 ]
Felip, E. [5 ]
机构：
[1] Vall dHebron Inst Oncol, Med Oncol, Barcelona, Spain
[2] Univ Hosp, Barcelona, Spain
[3] Vall dHebron Univ Hosp, Oncol, Barcelona, Spain
[4] Vall dHebron Univ Hosp, Oncol Data Sci, Barcelona, Spain
[5] Vall dHebron Univ Hosp, Lung Canc Unit, Med Oncol Serv, Barcelona, Spain
来源：
ANNALS OF ONCOLOGY | 2019年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1853P
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Real World use of Cisplatin and Carboplatin Based Therapy in Patients with Malignant Pleural Mesothelioma (MPM)
    Cedres, S.
    Assaf, J. D.
    Iranzo, P.
    Callejo, A.
    Pardo, N.
    Navarro, A.
    Martinez-Marti, A.
    Valdivia, A.
    Filipi-Arriaga, F.
    Monton, V.
    Gonzalo, J.
    Pedrola, A.
    Recasens, S.
    Madrenas, R.
    Feliu, B.
    Roman, B.
    Dienstmann, R.
    Felip, E.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S379 - S380
  • [2] Malignant pleural mesothelioma (MPM) in elderly patients: A multicenter survey
    Grosso, Federica
    Botta, Mario
    Zucali, Paolo Andrea
    Pasello, Giulia
    La Spina, Chiara Maria
    Roveta, Annalisa
    Perrino, Matteo
    Beretta, Giordano D.
    Polo, Valentina
    Santoro, Armando
    Favaretto, Adolfo G.
    Ceresoli, Giovanni Luca
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [3] A Real-World Analysis of the Use of Systemic Therapy in Malignant Pleural Mesothelioma and the Differential Impacts on Overall Survival by Practice Pattern
    Kerrigan, Kathleen
    Jo, Yeonjung
    Chipman, Jonathan
    Haaland, Benjamin
    Puri, Sonam
    Akerley, Wallace
    Patel, Shiven
    [J]. JTO CLINICAL AND RESEARCH REPORTS, 2022, 3 (03):
  • [4] Pemetrexed in combination with carboplatin in elderly patients with malignant pleural mesothelioma (MPM)
    Castagneto, B.
    Santoro, A.
    Ceresoli, G. L.
    Marangolo, M.
    Mencoboni, M.
    Zucali, P.
    Favaretto, A.
    Grossi, F.
    Bearz, A.
    Botta, M.
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2006, 60 : S18 - S18
  • [5] Outcomes of systemic therapy after first line therapy in patients (p) with malignant pleural mesothelioma (MPM)
    Cedres, S.
    Iranzo, P.
    Callejo, A.
    Pardo, N.
    Navarro, A.
    Martinez-Marti, A.
    Saoudi Gonzalez, N.
    Valdivia, A.
    Monton, V.
    Gonzalo, J.
    Pedrola, A.
    Dienstmann, R.
    Felip, E.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 : S1082 - S1082
  • [6] Dysphagia in Patients with Malignant Pleural Mesothelioma (MPM)
    Malec, M.
    Desai, A.
    Waxman, I.
    Karrison, T.
    Rose, B.
    Mendoza, A.
    Gadiraju, M.
    Straus, C.
    Churpek, J.
    Kindler, H.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S759 - S760
  • [7] Immune Checkpoint Inhibitor Uptake in Real-World Patients With Malignant Pleural Mesothelioma
    Kim, Roger Y.
    Mitra, Nandita
    Bagley, Stephen J.
    Marmarelis, Melina E.
    Haas, Andrew R.
    Rendle, Katharine A.
    Vachani, Anil
    [J]. JTO CLINICAL AND RESEARCH REPORTS, 2021, 2 (06):
  • [8] Multimodal Treatment of Malignant Pleural Mesothelioma: Real-World Experience with 112 Patients
    Holzknecht, Arnulf
    Illini, Oliver
    Hochmair, Maximilian J.
    Krenbek, Dagmar
    Setinek, Ulrike
    Huemer, Florian
    Bitterlich, Erwin
    Kaindl, Christoph
    Getman, Vladyslav
    Akan, Ahmet
    Weber, Michael
    Leobacher, Gunther
    Valipour, Arschang
    Mueller, Michael R.
    Watzka, Stefan B.
    [J]. CANCERS, 2022, 14 (09)
  • [9] STATIN USE AND SURVIVAL IN MALIGNANT PLEURAL MESOTHELIOMA (MPM)
    Cedres, S.
    Navarro, A.
    Martinez, A.
    Martinez, P.
    Ortiz, C.
    Farias, L.
    Felip, E.
    [J]. ANNALS OF ONCOLOGY, 2015, 26
  • [10] Real-World Survival Outcomes of Patients with Malignant Pleural Mesothelioma by Choice of Second-line Therapy
    Kerrigan, K.
    Chipman, J.
    Jo, Y. J.
    Haaland, B.
    Johnson, E.
    Puri, S.
    Varghese, T.
    Akerley, W.
    Patel, S.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S199 - S199
12345